×
About 3,963 results

ALLMedicine™ Growth Hormone Deficiency Center

Research & Reviews  1,883 results

Pituitary hypoplasia is the best MRI predictor of the severity and type of growth hormo...
https://doi.org/10.1515/jpem-2021-0049
Journal of Pediatric Endocrinology & Metabolism : JPEM; Sharma H, Purwar N et. al.

Apr 6th, 2021 - Congenital idiopathic growth hormone deficiency (GHD) is associated with various MRI abnormalities, including sellar and extrasellar abnormalities. However, it remains contentious whether MRI brain findings could provide an additional avenue for p...

Diagnosis and Management of Neuroendocrine Disorders of Survivors of Brain Tumors.
https://doi.org/10.1200/EDBK_321059
American Society of Clinical Oncology Educational Book. A... Erickson D, Donegan D

Apr 1st, 2021 - Advances in the treatment of brain tumors have led to an increase in the number of survivors of this disease. Consequently, the long-term complications associated with past and current treatments are becoming more apparent. Of relevance to patient...

Can plasma antioxidants prevent DNA damage in oxidative stress condition induced by gro...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016303
PloS One; Mancini A, Guidi F et. al.

Apr 1st, 2021 - Adult growth hormone deficiency (GHD), a condition characterized by increased oxidative stress, is related to augmented cardiovascular, metabolic and oncological risk. A case-control observational study has been performed to evaluate DNA oxidative...

see more →

Guidelines  4 results

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO...
https://journals.aace.com/doi/full/10.4158/GL-2019-0405
Endocrine Practice; Yuen KCJ,et al

Oct 31st, 2019 - The development of these guidelines is sponsored by the American Association of Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology (ACE) Board of Trustees and adheres with published AACE protocols for the sta...

Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the...
https://doi.org/10.1007/s40618-014-0201-7
Journal of Endocrinological Investigation; Aimaretti G, Attanasio R et. al.

Nov 4th, 2014 - Treatment of adolescents with growth hormone deficiency (GHD) during the transition period is a controversial issue. This paper is a contribution from the Italian community of paediatric and adult endocrinologists surveyed in a Delphi panel. The D...

Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clini...
https://doi.org/10.1210/jc.2011-0179
The Journal of Clinical Endocrinology and Metabolism; Molitch ME, Clemmons DR et. al.

May 23rd, 2011 - The aim was to update The Endocrine Society Clinical Practice Guideline on Evaluation and Treatment of Adult Growth Hormone Deficiency (GHD) previously published in 2006. Consensus was guided by systematic reviews of evidence and discussions throu...

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE F...
https://www.aace.com/files/growth-hormone-guidelines.pdf
David M. Cook

Sep 30th, 2009 - This report consists of recommendations for indications, diagnosis, and clinical use of GH in patients with biochemically proven GHD in transition years and in adulthood. However, it must be emphasized that physicians should use these guidelines c.

see more →

Drugs  23 results see all →

Clinicaltrials.gov  1,973 results

Pituitary hypoplasia is the best MRI predictor of the severity and type of growth hormo...
https://doi.org/10.1515/jpem-2021-0049
Journal of Pediatric Endocrinology & Metabolism : JPEM; Sharma H, Purwar N et. al.

Apr 6th, 2021 - Congenital idiopathic growth hormone deficiency (GHD) is associated with various MRI abnormalities, including sellar and extrasellar abnormalities. However, it remains contentious whether MRI brain findings could provide an additional avenue for p...

Diagnosis and Management of Neuroendocrine Disorders of Survivors of Brain Tumors.
https://doi.org/10.1200/EDBK_321059
American Society of Clinical Oncology Educational Book. A... Erickson D, Donegan D

Apr 1st, 2021 - Advances in the treatment of brain tumors have led to an increase in the number of survivors of this disease. Consequently, the long-term complications associated with past and current treatments are becoming more apparent. Of relevance to patient...

Can plasma antioxidants prevent DNA damage in oxidative stress condition induced by gro...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016303
PloS One; Mancini A, Guidi F et. al.

Apr 1st, 2021 - Adult growth hormone deficiency (GHD), a condition characterized by increased oxidative stress, is related to augmented cardiovascular, metabolic and oncological risk. A case-control observational study has been performed to evaluate DNA oxidative...

see more →

News  79 results

FDA OKs Somapacitan (Sogroya), First Once-Weekly Growth Hormone
https://www.staging.medscape.com/viewarticle/936834

Sep 2nd, 2020 - The US Food and Drug Administration (FDA) has approved somapacitan (Sogroya, Novo Nordisk) for the replacement of endogenous growth hormone in adults with growth hormone deficiency (GHD).  Somapacitan is a human growth hormone analog. It is admini...

FDA OKs Somapacitan (Sogroya), First Once-Weekly Growth Hormone
https://www.medscape.com/viewarticle/936834

Sep 2nd, 2020 - The US Food and Drug Administration (FDA) has approved somapacitan (Sogroya, Novo Nordisk) for the replacement of endogenous growth hormone in adults with growth hormone deficiency (GHD).  Somapacitan is a human growth hormone analog. It is admini...

Growth Hormone Deficiency Clinical Practice Guidelines (AACE/ACE, 2019)
https://reference.staging.medscape.com/viewarticle/924401

Jan 30th, 2020 - Guidelines for the management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care were published in 2019 by the American Association of Clinical Endocrinologists (AACE) and American College of Endocrinolo...

Growth Hormone Deficiency Clinical Practice Guidelines (AACE/ACE, 2019)
https://reference.medscape.com/viewarticle/924401

Jan 30th, 2020 - Guidelines for the management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care were published in 2019 by the American Association of Clinical Endocrinologists (AACE) and American College of Endocrinolo...

Don't Use Growth Hormone for Anti-Aging, Say New Guidelines
https://www.staging.medscape.com/viewarticle/922195

Dec 4th, 2019 - The 2019 Guidelines for Management of Growth Hormone Deficiency in Adults and Patients Transitioning from Pediatric to Adult Care issued by two key US endocrine societies cover important developments in the decade since the previous version.   The...

see more →

Patient Education  1 results see all →